Dual-tasking Effect on Gait in Children With Developmental Coordination Disorder

March 19, 2026 updated by: University Ghent

The Influence of an Interceptive Task on Gait in Children With Developmental Coordination Disorder Compared to Typically Developing Children

The aim of the study is to collect data in children with developmental coordination disorder (DCD) aged between 7 and 17 years for analyses of the gait pattern while walking at the Gait Real-time Analysis Interactive Lab (GRAIL) at the university hospital of Ghent.

Children with DCD will be asked to take a motor test (M-ABC-2) as well as walk on the treadmill during a single session of approximately 3 hours.

The following data will be collected on the GRAIL while subjects walk at different gait speeds: 3D kinematics, kinetics, and EMG.

Additionally, 3D kinematics, kinetics, and EMG data will be collected when performing either a cognitive (Stroop Color and Word Test) or motor (requiring arm swing) dual-task while walking at comfortable walking speed..

Study Overview

Status

Recruiting

Conditions

Detailed Description

The aim of the study is to collect data in children with developmental coordination disorder (DCD) aged between 7 and 17 years for analyses of the gait pattern while walking at the Gait Real-time Analysis Interactive Lab (GRAIL). This is a treadmill linked to a virtual environment used to analyse and train gait at the Children's Rehabilitation Centre of Ghent University Hospital. The data from children with DCD will be compared with typically developing children. In this study, only children with DCD will be included and the data resulting from this study will be compared to the data from the previous study in typically developing children (ID: B670201942108).

Children with DCD will be asked to take a motor test (M-ABC-2) as well as walk on the treadmill during a single session of approximately 3 hours. While walking at comfortable walking speed, two short games will be played i.e. dual-tasking. This involves both a cognitive (Stroop Colour-Word Test) and a motor (requires the use of the arms) dual task projected in the virtual environment of the GRAIL. The cognitive and motor task will be performed both while standing still (single tasking: ST) and while walking (dual tasking: DT). Simultaneously, kinetics, kinematics, and EMG data will be collected for 3D gait analysis. Using muscle synergy analysis (based on EMG data), the degree of gait automatization will be analysed. The data from children with DCD will be compared with typically developing children to determine whether a reduced gait automatization can be observed in children with DCD.

Parents will be asked to complete a screening list (CVO/DCD-Q) for motor problems in daily life. This aims as a support to the motor test (M-ABC-2), together providing additional insight into children's motor functioning (in daily life).

Study Type

Interventional

Enrollment (Estimated)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Ghent, Belgium, 9000
    • East-Flanders
      • Ghent, East-Flanders, Belgium, 9000
        • Recruiting
        • Ghent University
        • Contact:
          • Lynn Bar-On, Prof.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • They have an official DCD diagnosis;
  • Are aged between 7 and 17 years old;
  • Can walk at least 15 minutes consecutively;
  • Have good or corrected vision.

Exclusion Criteria:

  • They suffer from a neurological disorder;
  • Take medications that affect gait and balance;
  • Have undergone surgical procedures on the lower limbs in the past;
  • Experience pain in their lower limbs or back at the time of testing.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treadmill walking
Participants will be asked to walk at different gait velocities for 1 minute. The treadmill speed will be increased incrementally at 0.1m/s intervals until just before running. The comfortable walking speed will be determined.
Participants will be asked to walk at comfortable walking speed while playing an additional cognitive task, namely the Stroop Color and Word Test.
Participants will be asked to walk at comfortable walking speed while playing an additional motor task, namely a game that requires arm swing to hit the targets.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kinematics
Time Frame: Single point assessment, day 1
3D kinematics of lower and upper limb joints while walking (degrees)
Single point assessment, day 1
Kinetics
Time Frame: Single point assessment, day 1
3D kinetics of lower limb joints while walking (Nm)
Single point assessment, day 1
EMG
Time Frame: Single point assessment, day 1
Muscle activity of 16 lower limb muscles (microvolts)
Single point assessment, day 1
Muscle synergies
Time Frame: Single point assessment, day 1
Synergy analysis will be conducted using the EMG data (variance accounted for -VAF)
Single point assessment, day 1
Spatiotemporal parameters
Time Frame: Single point assessment, day 1
Spatial parameters (m), temporal parameters (s), walking velocity (m/s)
Single point assessment, day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait deviation index
Time Frame: Single point assessment, day 1
Based on kinematics, the lower-limb gait deviations will be calculated (degrees)
Single point assessment, day 1
Game result (cognitive task)
Time Frame: Single point assessment, day 1
Score (% correct)
Single point assessment, day 1
Game result (motor task)
Time Frame: Single point assessment, day 1
Score (% correct)
Single point assessment, day 1

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographic data
Time Frame: Single point baseline assessment
Gender, age
Single point baseline assessment
Anthropometric data (height)
Time Frame: Single point baseline assessment
Height and segment lengths (cm)
Single point baseline assessment
Anthropometric data (weight)
Time Frame: Single point baseline assessment
Weight (kg)
Single point baseline assessment
M-ABC-2
Time Frame: Single point baseline assessment

Standardized tool to identify motor functioning in children (standard score between 1 and 19)

Standard scores indicate:

  • Significant motor difficulty: standard score < 6
  • Minor motor difficulties: standard score 6 or 7
  • No motor difficulty: standard score > 7
Single point baseline assessment
Developmental Coordination Disorder Questionnaire (DCDQ)
Time Frame: Single point baseline assessment

Brief parent questionnaire to screen for coordination disorders in children (total score between 15-75)

Children score suspected/an indication for DCD when:

  • Age 5-7: score of <47
  • Age 8-9: score of <56
  • Age 10-15: score of <58
Single point baseline assessment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lynn Bar-On, University Ghent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 12, 2024

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Study Registration Dates

First Submitted

May 1, 2024

First Submitted That Met QC Criteria

May 1, 2024

First Posted (Actual)

May 6, 2024

Study Record Updates

Last Update Posted (Actual)

March 20, 2026

Last Update Submitted That Met QC Criteria

March 19, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gait

Clinical Trials on Cognitive dual-task

Subscribe